Marinus Pharmaceuticals Inc (MRNS)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Scott N. Braunstein |
| Employees: | 110 |
| Web site: | marinuspharma.com |
|
5 RADNOR CORPORATE CENTER SUITE 500, 100 MATSONFORD RD, RADNOR, PA, 19087
484-801-4670
| |
Are you looking for this stock instead?
| Date | Ratio |
|---|---|
| 2020-09-23 | 1:4 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Marinus Pharmaceuticals, Inc. offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder. It is developing ganaxolone for treating genetic epilepsy disorders, such as PCDH19-related epilepsy, tuberous sclerosis complex, depressive disorders, and Lennox-Gestaut Syndrome.
Please log in first to see chart